Building the next generation of therapies through translational science.

Many leading obesity and diabetes therapies remain injectable, costly and difficult to sustain.

Rapid strides have been made in treatment of diabetes and weight loss both of which are a global problem. However, treatments are still peptide (injection) based and high cost that are barriers to adoption specially in developing economies